产品编号:P139935
产品规格:1mg
产品价格:面议
| 标准品编号: | P139935 |
| 名称: | Palbociclib Rearranged Lactose Adduct |
| 别名: | 6-Acetyl-8-cyclopentyl-5-methyl-2-((5-(4-((3S,4R,5R)-3,5,6-trihydroxy-2-oxo-4-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexyl)piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one |
| 分子式: | C₃₆H₄₉N₇O₁₂ |
| 分子量: | 771.81 |
| 类别: | Standards; Molecular Biology; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Palbociclib Lactose Adduct is a lactose adduct of Palbociclib (P139900), an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
| 参考文献 | |